NOVAVAX COVID-19 Vaccine, Adjuvanted
- Product NDC
- 80631-100
- 11-digit product format
- 806310100
- Labeler code
- 80631
- Product ID
- 80631-100_88d602f8-31fb-45bd-b142-9024c69f4daa
- Type
- VACCINE
- Nonproprietary name
- nvx-cov2373
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- Novavax, Inc.
- Marketing category
- EMERGENCY USE AUTHORIZATION
- Marketing start
- 2022-01-31
- Marketing end
- 0000-00-00
- Substance
- SARS-COV-2 SPIKE GLYCOPROTEIN VACCINE ANTIGEN NVX-COV2373
- Active strength
- 5 ug/.5mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 80631-100-10 | 80631010010 | 10 VIAL, MULTI-DOSE in 1 CARTON (80631-100-10) > 5 mL in 1 VIAL, MULTI-DOSE (80631-100-01) | 2021-04-23 | 0000-00-00 | No | No | Current |